Multiple Sclerosis Flashcards

1
Q

Pathophysiology of MS

A

. White matter demyelination with lymphocytic infiltration

. Axonal damage and brain atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology

A

. Common in female
. Symptoms 20-50 yrs
. Peak 30 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Patterns of MS

A
1. Relapsing Remitting:
Most common (85%) - One attack/yr - Disability accumulates over time - 50% end up secondary progressive
2. Secondary progressive:
steady deterioration w/o acute relapse
3. Primary progressive:
10-15% - gradual & continuous deterioration w/o relapse
4. Progressive relapsing:
5% - high mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of MS divide into

A

Motor
Sensory
Cognitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lhermitte’s Sign

A

Sudden sensation of electric shock passes down from neck into the back, arms and legs.

  • Increased by neck flexion.
  • Result of the increased sensitivity of
    the myelin to stretch or traction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prognostic Signs of MS

A

Good: Female, <35yo, sensory / optic, relapsing remitting.

Bad: Male, >35yo, motor / cerebellar, progressive relapsing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outcome Measures of MS

A

1) Expanded Disability Status.
2) Multiple Sclerosis Impact Scale
3) Hamburg Quality of Life Questions in MS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Things to be considered before putting exercise plan in MS

A
  • May worsen symptoms, increase core temp
  • Avoid overload
  • Passive and active ROM
  • Aerobic Training
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Consideration before starting rehabilitation in MS patients

A

1) Fatigue
2) Spasticity
3) Ataxia
4) Incoordination
5) Neurological deficit

Target: range limitation and strength deficit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
Fatigue in MS
A. Define.
B. Access.
C. Treat.
D. Risk Factors.
A

Definition: subjective lack of physical or mental capacity to preform usual activities.

1) Fatigue descriptive 2) Fatigue severity 3) Fatigue Impact.

Tx: Amatadine – Modafinil “after” Rule out: poor sleep hygiene and medical diseases.

Risks: Heavy meal – Exercise – Heat – Hot Shower.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Uhthoff’s Phenomenon

A

Visual problems with MS patient reporting back spots BL when they are exposed to heat (exercise, weather, shower, sauna, fever).

  • Myelin dysfunction when surrounded fluid heats up.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complication of spasticity in MS?
Risk Factors?
Exercises?
Pharmacological and Non-Pharmacological Tx?

A

1) ADL: touch, proprioception, hand skills, strength.
2) Movement: increased tone – overflow pattern – unintentional agonist-antagonist contraction.

Risks: UTI, pressure sore, constipation “bed bound”.
- An increase in spasticity may be an indication of a coexisting condition including infection & trauma.

Non-Pharmacological Tx

1) Stretch: day & night (spasm)
2) Active ROM
3) Assistant Exercises

Pharmacological Tx:

1) Baclofen (y-aminobutyric) ½ life 1.5-4hrs
2) Benzo: Valium (Diazepam), Colanzepam

Combination of:

  • 3 agents
  • local Injection (neurolysis or botulium toxin)
  • Drosal Root Rhinozotomy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lines of Tx for spasticity in MS?

A

1st Line: Daily positioning – Stretch – Splinting
2nd Line: Oral Agent (Baclofen 5-10mg)

Local Spasticity: Local Botulium Toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The autoimmune response in MS causes.

“What would you see in CT image”

A

1) demyelination
2) axonal damage
3) brain atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pregnancy in MS

A

Decreases relapses, then increases after delivery. No change long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common symptoms in MS (List 10)
Frontal – Temporo-Parital – Corticospinal – Occipital/eye – Cerebellar – Brain stem – Dorsal Column – Body & Bladder.

A

1) Bladder and Bowel dysfunction
2) Fatigue (Central in nature)
3) Pain
4) Visual disturbances: Optic neuritis, diplopia, nystagmus
5) Cerebellum and basal ganglia: ataxia, intention tremor
6) Doral column: Sensory abnormalities (paresthesias),
impairment of deep sensation, proprioception
7) Corticospinal tract: Weakness and spasticity
8) Frontal lobe dysfunction: Cognitive, memory,
learning, and impaired emotional responses,
depression
9) Speech abnormalities: Dysarthria
10) Brainstem abnormalities: Myokymia, deafness,
tinnitus, vertigo, vomiting, transient facial
anesthesia, dysphagia

17
Q

Top 3 problems affecting ADLs reported by patients

A
  1. Fatigue
  2. Weakness
  3. Balance difficulties
18
Q

All new symptoms result from new MS lesion. (Yes/No)

A

Aggravation of symptoms in old and previously silent lesions may be caused by fever, heat, stress, fatigue, or other medical problems, especially pulmonary or urinary tract infection, dehydration or medication
side-effects.

19
Q

MS
Dissemination in time?
Dissemination in space?

A

DIT: lesion at any time, follow up T2, clinical attack
DIS: 1 lesion in 2 areas in typical regions.

A) 2 Attacks + 2 Clinical Lesions “OR”
2 Attacks + 1 Clinical Lesion + Prior attack of another lesion not yet found
B) 2 Attacks + 1 Clinical Lesion “AND”
DIS 1 Attack of another lesion “OR”
DIS 1+ Lesions in 2+ Areas
C) 1 Attack + 2 Clinical Lesions “AND”
DIT another attack
DIT new or enhancing MS-typical MRI lesions compared to baseline
CSF +ve Oligoclonal bands
20
Q

Cerebral Spinal Fluid (CSF) Examination in MS

A

1) Increased in Protein (myelin basic, 25%)
2) Oligoclonal IgG bands (greatest sensitivity)
3) WBCs

21
Q

Describe the changes seen in MS patient

1) VEP (Visual Evoked Potentials)
2) BAER (Brainstem Auditory Evoked Response)
3) SEP (Sensory Evoked Potentials)
4) EMG/NCS

A

1) P100 latency is abnormal (slowing secondary to plaques) in 75%
2) Testing the pontine area displaying an absence or delay of wave formation secondary to the demyelinating process.
3) Prolongation of absolute peak or interpeak latency
4) Fibs, Positive Sharp Waves (PSW), Facial myokymia and a decrease Motor Unit Action Potentials (MUAP)

22
Q

Medical Treatment of MS

A
  1. Corticosteroids (Methylprednisolone)
  2. Immunomodulator agents: Disease-modifying
  3. Immunosuppression agents

1st Line:
Interferon – Gtalimramer Acetate – Tecfidera – Gilynea

2nd Line:
Gilynea - Tysabri – Lemtrada - Ocrevus

23
Q

Corticosteroids (Methylprednisolone) in MS

A
  • Used in acute attacks = “exacerbation”
  • Most responsive symptoms: Optic neuritis, brainstem, motor, acute pain, bowel and bladder.
  • Least responsive: Cerebellar, sensory.
  • Pulse therapy: ~1000mg/day Intravenous IV for 4–7days with a 2 week taper, switch to PO
  • Increase risk of HTN, osteoporosis, diabetes, and cataracts
  • Does not prevent further attacks or alter disease progression
24
Q

Exercise in MS

A
  • Exercise improves conditioning not weakness.
  • Aerobic training increases endurance. Light progressive resistive exercises prevent disuse atrophy.
  • Do not exercise to the point of fatigue.
  • Fatigue worsens with increased temperature, stress, and activity
  • Swimming should be done at a cool temperature.
  • Heat worsens the condition, secondary to delaying impulse conduction.
25
Pathology of Incoordination, Ataxia, Tremor, Dysmetria in MS? How to rehab?
Pathology: White matter tracts spinocerebellar, cerebrum, and dorsal columns. Rehabilitation includes: PT and OT for balance training, weighted ankle cuffs, Frenkel’s exercises.
26
Visual Impairment/Eye examination in MS? | Treatment?
Clinical: Blurred vision, complete or partial loss of vision, painful movement. A central scotoma (area of blindness). Treatment: IV methylprednisolone is more effective than PO prednisone
27
Bladder Dysfunction in MS Failure to Store Failure to Empty
1. Failure to Store: - Incontinence, dribbling of urine - Hyperactive bladder with a small capacity and weak sphincter (adrenergic) - Smooth muscle relaxant (detrusor) Anticholinergic Oxybutynin (Ditropan) 2. Failure to Empty: - Failure to void - Smooth muscle contractor Urecholine or Alpha antagonist Minipres - Intermittent Catheterization